SEC Form 4 · accession 0001144204-15-001926
Propanc Health Group Corp · PPCB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Andrew Nathanielsz
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Sep 4, 2012
Accepted (ET)
Jan 13, 2015 · 9:04 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001517681
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1 | Sep 4, 2012 | S | 250,000 | $0.20 | D | 9,782,261 | I | North Horizon Investments As Trustee for Nathanielsz Family Trust |
| Common stock, par value $0.001 per shareF1 | Sep 14, 2012 | S | 5,000 | $0.20 | D | 9,777,261 | I | North Horizon Investments As Trustee for Nathanielsz Family Trust |
| Common stock, par value $0.001 per shareF1 | Dec 13, 2012 | S | 5,500 | $0.20 | D | 9,771,761 | I | North Horizon Investments As Trustee for Nathanielsz Family Trust |
| Common stock, par value $0.001 per shareF1 | Jan 23, 2013 | S | 15,000 | $0.20 | D | 9,756,761 | I | North Horizon Investments As Trustee for Nathanielsz Family Trust |
| Common stock, par value $0.001 per shareF1 | Jul 5, 2013 | S | 55,000 | $0.0906 | D | 9,701,761 | I | North Horizon Investments As Trustee for Nathanielsz Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF1,F2 | — | Nov 9, 2014 | A | 500,000 | A | — | — | Preferred Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1This Form 4 is a late filing reporting the changes in beneficial ownership of the Reporting Person as of September 4, 2012, September 14, 2012, December 13, 2012, January 23, 2013, July 5, 2013 and December 9, 2014. The Reporting Person voluntarily filed a Form 3 on July 26, 2012.
- F2Each share of the issuer's Series A Preferred Stock (the "Preferred Stock) is entitled to five hundred (500) vote of whole shares of common stock at the record date for the determination of stockholders entitled to vote on such matters or, if no such record date is established, at the date such vote is taken or any written consent of stockholders is solicited, exercisable immediately following the issuance of the Preferred Stock on December 9, 2014 with no expiration date.